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ABSTRACT 
 
Viral epidemics in the pork industry continue to plague the agricultural industry, 
national food security, and human health. Current preventative measures are insufficient 
for deterrence as viruses rapidly mutate and reemerge despite vaccinations and 
biosecurity. In order to prevent viral outbreaks within and between pork facilities, 
alternative measures are needed.  
The innate immune system is a host’s first response to pathogens. It offers a rapid 
response; however, it does not have the specificity which is seen in the adaptive immune 
system. In its initial response, cytokines IFNα and IFNβ induce expression of interferon 
stimulated genes to inhibit viral replication within the cell. IRF-7 has been identified as 
the master regulator of type I IFN transcription and is tightly controlled by OASL and 
4E-BP1, binding to the secondary structure of its 5’ UTR. To enhance the innate 
immune system response to viruses, the DNA sequence for the 5’ UTR of IRF-7 in 
porcine cells was modified using the CRISPR/Cas9 gene editing system. Following UTR 
modifications, 9 modified cell lines were produced and clonally selected, along with 2 
control cell lines that were not modified. All cell lines were transfected with poly I:C to 
induce the innate immune response and transcript levels of genes associated with the 
IFN pathway analyzed by RT-qPCR.  
Deletions induced by the CRISPR/Cas9 system in cell lines successfully altered 
the IRF-7 5’ UTR DNA sequence in 82% of cells. RNA folding predictions of the two 
modified cell lines with a heightened immune response show drastic alterations to the 
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IRF-7 5’ UTR in regions hypothesized to be critical for IRF-7 translational regulation. 
Understanding the relationship of the 5’ UTR secondary structure and IRF-7 regulation 
allows for the possibility of enhanced innate immune responses in animal models with 
IRF-7 5’ UTR modifications or even in targeting the IRF-7 5’ UTR in humans using 
pharmacological substances.  
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miRNA microRNA 
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MAPK MAP Kinase 
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ZFN Zinc Finger Nickases  
RELA REL Associated Protein 
PAM Protospacer Adjacent Motifs 
crRNA Precursor CRISPR RNA 
DSB Double Strand Break 
NHEJ Non Homologous End Joining 
HDR Homologous Directed Repair 
gRNA Guide RNA 
EST Expressed Sequence Tag 
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PCR Polymerase Chain Reaction 
NCBI National Center for Biotechnology Information 
SK6 Swine Kidney Cells 
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Poly I:C Polyinosinic:Polycytidylic Acid 
RT-qPCR Reverse Transcription Quantitative PCR 
UCSC University of California Santa Cruz 
ELISA Enzyme Linked Immunosorbent Assay 
 
xi 
TABLE OF CONTENTS 
Page 
ABSTRACT ...................................................................................................................... ii 
DEDICATION ..................................................................................................................iv 
ACKNOWLEDGEMENTS ............................................................................................... v 
CONTRIBUTORS AND FUNDING SOURCES .............................................................vi 
NOMENCLATURE ........................................................................................................ vii 
TABLE OF CONTENTS ..................................................................................................xi 
LIST OF FIGURES  ........................................................................................................ xiii 
CHAPTER I  INTRODUCTION  AND  LITERATURE  REVIEW .................................. 1 
Impact of Disease in the Pork Industry .......................................................................... 1 
Functional mechanisms of the innate immune system ................................................... 4 
Initiation of type I IFN production ............................................................................. 7 
Type I IFN Signaling ................................................................................................ 21 
Genetic Engineering Using the CRISPR/Cas System .................................................. 28 
CHAPTER II  MATERIALS  AND  METHODS .............................................................. 31 
CRISPR/Cas mediated modification of porcine IRF-7 5’ UTR ................................... 31 
IRF-7 RNA prediction and structure ........................................................................ 31 
Guide RNA design and construction ........................................................................ 31 
Cells and reagents ..................................................................................................... 32 
Preliminary guide RNA transfections and efficiency determination ....................... 32 
Primary gRNA transfections .................................................................................... 33 
Cell selection and clonal propagation ...................................................................... 35 
Interferon and ISG response in cells containing modified IRF-7 5’ UTR ................... 35 
Poly I:C transfection ................................................................................................. 35 
Analysis of mRNA expression by quantitative reverse transcription PCR .............. 36 
Statistics and data analysis ....................................................................................... 36 
CHAPTER III  RESULTS ............................................................................................... 38 
CRISPR/Cas mediated modification of porcine IRF-7 5’ UTR ................................... 38 
5’UTR Sequencing ................................................................................................... 38 
Guide RNA Design .................................................................................................. 40 
xii 
Guide RNA Subcloning ............................................................................................ 40 
Guide functionality and efficiency ........................................................................... 41 
Modified cell line development ................................................................................ 43 
RNA Folding predictions of the modified cell lines’ IRF-7 5’ UTR ....................... 47 
Modified cell line IFN stimulation ............................................................................... 49 
Poly I:C stimulation and gene expression ................................................................ 49 
CHAPTER IV  DISCUSSION ......................................................................................... 55 
REFERENCES ................................................................................................................. 61 
APPENDIX ...................................................................................................................... 73 
 xiii 
 
 
LIST OF FIGURES 
 Page 
Figure 1: Overview of the innate immune response........................................................... 6 
Figure 2: Biphasic activation of type I IFNs .................................................................... 11 
Figure 3: Predicted folding of the murine IRF-7 5' UTR ................................................. 14 
Figure 4: Transfection treatment groups for the development of modified cell lines ...... 34 
Figure 5: Amplified genomic sequence of porcine IRF-7 ................................................ 39 
Figure 6: Guide RNAs designed to target 6 unique locations within the IRF-7 5’ UTR . 40 
Figure 7: Four gRNAs caused cleavage bands in the gel electrophoresis of a T7 
Endonuclease 1 assay ....................................................................................... 42 
Figure 8: Deletions within the IRF-7 5’ UTR ranged from 6 base pairs to 191 base 
pairs ................................................................................................................... 46 
Figure 9: CRSPR/Cas9 induced deletions altered the predicted secondary structures of 
the IRF-7 5’ UTR .............................................................................................. 48 
Figure 10: Collected data failed tests for normality ......................................................... 51 
Figure 11: Selection and clonal propagation of SK6 cells does not alter gene 
expression profiles. ........................................................................................... 52 
Figure 12: Genetic modification of the IRF-7 5' UTR does not alter unstimulated gene 
expression ......................................................................................................... 53 
Figure 13: Specific cell lines have increased response to poly I:C. ................................. 54 
 1 
 
 
CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
Impact of Disease in the Pork Industry 
Agricultural sustainability and food security is a growing concern worldwide as 
the world population continues to increase at a tremendous rate. The world’s population 
is estimated to grow to 9 billion by 2050 and there is a preexisting strain on the 
agricultural industry, as 1 out of 7 people do not have access to adequate protein or 
energy (Godfray et al., 2010). Worldwide demand for agricultural products is already 
rising past what the current international agricultural industry can supply. The increase 
in demand for animal protein is not only contributed to by the population rise, but by 
economic growth, rapid urbanization, and an increase in wealth (Godfray et al., 2010; 
Herrero and Thornton, 2013). Despite the increase in agricultural efficiency in the past 
few decades, the competition for land use is limiting the growth of both plant and animal 
crops resulting in the need for genetic research to continuously enhance crop and animal 
performance (Godfray et al., 2010).  Recently the largest increase in livestock production 
efficiency has been witnessed in monogastric animals such as poultry and swine. 
Through years of selecting for high producing pigs and the vertical integration of the 
pork industry, pork production has become one of the most efficient sources of animal 
protein, a major contribution to the nation’s and the world’s food security. The nation’s 
pork production has been growing approximately 3% each year but the maximization of 
the pork industry has also increased the risk of disease outbreaks (Herrero and Thornton, 
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2013). Although pork production is extremely efficient, its Achilles’ heel is the 
continuous viral epidemics that effect the industry as well as the consumers.   
Despite best efforts, the US pork industry is extremely vulnerable to future 
pathogenic outbreaks, such as Porcine Epidemic Diarrhea virus (PEDv), Porcine 
Reproductive and Respiratory Syndrome Virus (PRRSV), Swine Influenza Virus (SIV), 
Porcine Respiratory Coronavirus (PRCV), Classical Swine Fever Virus (SFV), as well as 
Foot and Mouth Disease Virus (FMDV), which could all cause significant economic 
loss. For example, in 2013, the United States pork industry was crippled by an outbreak 
of PEDv. Due to the rapid transmission of this virus, it quickly spread throughout the 
country and across international borders into Canada as well as Mexico. This resulted in 
the sudden loss of 7 million piglets, 10% of the United States’ domestic pig population, 
within the year (Jung and Saif, 2015). Due to the massive loss in animals, the annual 
economic loss is estimated to be $900 million to $1.8 billion (Annamalai et al., 2015; 
Paarlberg, 2014). PEDv has contributed to viral outbreaks since the early 1970s, 
however, despite an increase in biosecurity of pork facilities and an intense vaccination 
protocol, the virus mutated and spread swiftly; most likely by transport trailers (Dee et 
al., 2014; Jung and Saif, 2015; Lowe et al., 2014). This is an extremely worrying 
example which illustrates that viral epidemics, such as was seen with PEDv, are able to 
infect animals despite vaccination and biosecurity protocols (Jung and Saif, 2015). 
Another intriguing issue is the susceptibility of pigs to both avian and human 
influenza viruses, allowing for the creation of zoonotic diseases, threatening not only 
food security, but human health as well (Kida et al., 1994). The best example of this is 
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SIV, which is known to use pigs as a “mixing reservoir” to allow for these viruses, 
usually originating from an avian source, to mutate into transspecies viruses and 
affecting humans (Kothalawala et al., 2006). Although SIV is not known to be cause 
high mortality rates, the loss of productivity, withdrawal time, and threat to human 
health burdens the industry.  
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Functional mechanisms of the innate immune system 
The first defense against pathogens in mammals is the innate immune system, 
expressed in almost every mammalian cell. Upon recognition of a viral infection, the 
porcine innate immune system immediately initiates several pathways to create an anti-
viral state. The most important response to pathogens involves interferons, which are 
cytokines expressed in most cells with potent anti-viral and growth inhibitory effects 
(Platanias, 2005). Upon infection, pathogen recognition receptors (PRRs) on the cell 
membrane, in the cytosol, and on endosomal compartments, recognize bacterial and viral 
components, (McNab et al., 2015; Ning et al., 2011). The most important of these 
receptors are the Toll-like receptors (TLR) on the cell membrane. Upon recognition of 
viral infection, TLR receptors activate TANK Binding Kinase 1 (TBK1) which 
phosphorylate interferon regulatory factor (IRF) 3 and a small amount of IRF-7 which 
are then translocated to the nucleus, as seen in Figure 1 (McNab et al., 2015; Ning et al., 
2011). The initial phosphorylation of IRF-3 and IRF-7 both allow for the transcription of 
Type I Interferons (IFNs) which, in turn, activates additional IRF-7 to create a positive 
feedback loop and increases Type I IFN production, (McNab et al., 2015). Type I IFNs 
are robust cytokines which inhibit the translation of viral mRNAs through many 
pathways in order to create an ant-viral state in the cell (Platanias, 2005). The Type I 
IFNs, most commonly IFNα and IFNβ, bind to IFNAR1 and IFNAR2 transmembrane 
receptors which ligate and activate Janus kinase I (JAK 1) and tyrosine kinase 2 (TYK 
2). Upon autophosphorylation and activation of JAK 1 and TYK 2, several different 
immune pathways are induced, one being the signal transducer and activator of 
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transcription (STAT) 1 and 2 pathway. STAT 1 and STAT 2 bind to IRF-9 to form the 
interferon stimulated gene factor 3 (ISGF3) complex which initiates transcription of 
interferon stimulated genes (ISG) as well as increases the synthesis of more IRF-7. The 
transcription of ISGs cause the anti-viral state of the infected cell, as well as in 
neighboring cells, to limit the spread of the viral infection and continue production of 
IRF-7 which sustains the transcription of Type I IFNs, (McNab et al., 2015; Ning et al., 
2011). Although only a few pathways to initiate IFN production have been mentioned, 
there are several others that contribute to IFN responses. The activation of multiple 
pathways simultaneously are required to trigger the production of IFN; one pathway 
alone is not sufficient, which minimizes IFN expression when a pathogen is not present, 
(Platanias, 2005). Efficient interferon production in an animal is critical for its survival 
against pathogens. Even more important than interferon production itself is the positive 
feedback loop between IRF-7 and IFN, which regulates the amount of interferon 
transcription, ISG transcription, and the amplitude of the animals’ response to 
pathogens. 
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Figure 1: Overview of the innate immune response (McNab et al., 2015) 
  Upon recognition of viral pathogens, PRRs such as TLRs, DAI, MDA5, or RIG1 activate 
TBK1 and IKKε which phosphorylate IRF-3 and IRF-7. IRF-3 and IRF-7 translocate to the 
nuclease and, along with NF-κB, induce the transcription of type I IFNs. In a different 
pathway, TLR 7, TLR8, and TLR9 within the endosome may also recognize viral 
components and activate the MYD88 pathway which also activates IRF-3 and IRF-7. 
Following the induction of transcription, type I IFNs bind to its receptors on neighboring 
cells and initiates the JAK-STAT pathway which leads to ISG transcription. Adapted from 
(McNab et al., 2015). 
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Initiation of type I IFN production 
 Interferons are a very broad family of cytokines that are instrumental in innate 
and adaptive immunity. Type I IFNs, IFNα and IFNβ, are innate cytokines that initiate 
the antiviral state of the cell and work to prevent viral intracellular viral replication. 
There are other type I IFNs however, IFNα and IFNβ are the most potent and critical for 
proper innate immune system function. IFNγ is the only type II IFN but is an important 
cytokine, bridging the innate and adaptive immunity.  IFNγ, produced by natural killer 
(NK) and T cells, is a potent activator of innate macrophages and has several other roles 
in the immune system beyond the innate system (Schoenborn and Wilson, 2007). Type 
III IFNs consist of IFN λ1-4 and were previously described as interferon-like cytokines 
and interleukin (IL) 28. IFN λ has similar functions to type I IFNs but are much more 
restricted (McNab et al., 2015). Although IFNs are all important to overall immune 
function, only type I IFNs, IFNα and IFNβ, will be discussed further.  
 Pathogens and their components are recognized by several different pathogen 
recognition receptors (PRRs) depending on the location of pathogen and what the nature 
of its pathogen associated molecular patterns (PAMP) are. TLRs, a family of PRRs, are 
present at several different locations of the cell such as in endosomes, in the cytosol, and 
on the cell surface. This broad range of receptor locations allows the cell to identify a 
wide range of pathogens, both intracellular and extracellular. As the cell is transporting 
broken down fragments of pathogens in endosomal compartments, the receptor within 
those compartments, TLR3, can recognize single and double stranded RNA as well as 
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DNA containing CpG islands to induce type I IFN expression (Der et al., 1998; McNab 
et al., 2015). Several extracellular pathogens present unique PAMPs which can be 
identified by PAMP specific PRRs, located on the cellular membrane, such as TLR4 
recognizing lipopolysaccharides (LPS) from bacterial infections. The canonical signaling 
for type I IFN induction is usually initiated by TLR3 and TLR4, influencing the adaptor 
protein TIR domain-containing adaptor protein inducing IFNβ (TRIF) activation of 
TBK1(McNab et al., 2015). In addition to the TLRs, RNA helicase retinoic acid 
inducible gene I (RIG-I), melanoma differentiation associate gene 5 (MDA5), and DNA-
dependent activator of IRF (DAI), which are located within the cytosol, mainly 
recognize intracellular viral RNA. These receptors utilize mitochondrial antiviral 
signaling protein (MAVS) to activate TBK1 (McNab et al., 2015; Paludan and Bowie; 
Takaoka et al., 2008).  Also in the cytoplasm, NOD-containing protein (NOD) 1 and 
NOD2, which are molecular sensors, recognize several different ligands and foreign 
nucleic acids (McNab et al., 2015; Moreira and Zamboni, 2012). Following the 
activation of TBK1 by certain PRRs, kinase IκB kinase-ε (IKKε) along with TBK1, 
phosphorylate IRF-3 and IRF-7 (McNab et al., 2015). Plasmacytoid dendritic cells 
(pDCs) express TLR7 and TLR9 which, unlike the previous receptors, utilizes the 
myeloid differentiation primary response protein 99 (MYD88) signaling pathway, 
known as the MYD88 dependent pathway, instead of activating TBK1 for type I IFN 
induction (McNab et al., 2015; Moynagh, 2005). These signaling pathways are all 
unique and synchronous to facilitate proper type I IFN transcription and innate immunity 
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function. The phosphorylation of IRF-3 and IRF-7 by such pathways are key mediators 
in type I IFN transcription for the inhibition of intracellular viral replication. 
IRF family and the induction of IFN transcription 
 The interferon regulatory factor (IRF) family are transcription factors with 9 
members (IRF1-9) which frequently interact with ISGs, STATs, and other IRF family 
members in order to control type I IFN transcription, adaptive immune cell development, 
as well as regulate oncogenesis (Ning et al., 2011). Another member, IRF-10, has been 
identified but is only present in avian species (Nehyba et al., 2002). Genes encoding 
IRFs are highly conserved among vertebrates and originated in metazoans, directly 
associated with the formation of multi-cellular organisms (Nehyba et al., 2009). In most 
non-lymphatic cells, IRF-7 resides inactive in the cytoplasm until the recognition of a 
pathogen and the induction of type I IFNs by IRF-3. 
IRF-7 has similar homology to IRF-3 and is stimulated with the same PRRs as 
IRF-3, however, IRF-7 translation can also be initiated by, TLR7, TLR8, and TLR9 
(Takaoka et al., 2008). In the canonical pathway, the activation by phosphorylation of 
IRF-7 is the second phase of type I IFN transcription induction and is the most potent 
stimulation, leading to the identification of IRF-7 as the master regulatory of type I IFNs 
and their signaling pathways (Honda et al., 2005; Sato et al., 2000). However, IRF-7 
translation can also be directly activated without the initial IFN burst induced by IRF-3, 
as discussed below. There are certain PAMPs that will cause the cellular receptors to act 
directly upon IRF-7 such as viral or bacterial double stranded RNA (dsRNA) with CpG 
islands, among others (Ning et al., 2011; Yang et al., 2003). In addition to direct 
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pathogen and type I IFN activation, IRF-7 translation can be induced by 12-o-
tetradecanoylphonl-13-acetate, tumor necrosis factor α (TNFα), and LPS (Ning et al., 
2011).  
In the canonical pathway, following the recognition of a pathogen, type I IFN 
transcription is initiated biphasically by IRFs, Figure 2 (Sato et al., 2000). First, IRF-3, 
which is expressed constitutively in almost all cells, is activated by phosphorylated with 
the viral induction of PRRs such as TLR3, TLR4, RIG-1, MDA5, and DAI. In an 
MYD88 independent activation by TLR3 or TLR4, IRF-3 is phosphorylated by IKKε 
and TBK1, then translocated to the nucleus to induce type I IFNs, specifically IFNβ 
(Takaoka et al., 2008). However, in pDCs, IRF-7 may be phosphorylated by IKKα and 
IRAK1, however, more studies are needed to confirm this observation (Hoshino et al., 
2006; Ning et al., 2011; Uematsu et al., 2005). Following phosphorylation, IRF-3 
stimulates an initial burst of IFNβ transcription and is just enough to stimulate ISG 
expression for the second induction of type I IFNs. After the initial burst of IFNβ, IFN-
activated transcription factor (ISGF3), which contains IRF-9 and STAT1/2, is activated 
and not only binds directly to inducible elements of IFNα and IFNβ, but also directly 
induces IRF-7 translation (Ivashkiv and Donlin, 2014; Sato et al., 1998). IRF-3 is an 
instrumental player in type I IFN transcription, however, it does not contribute to the 
pathway in the absence of IRF-7, suggesting that IRF-7 is the critical regulator (Honda et 
al., 2005).  
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Type I IFNs require a biphasic activation. The early phase is critical for maintenance of IFN 
receptors and quick activation while the late phase is important for viral response. Modified from 
(Sato et al., 2000). 
Figure 2: Biphasic activation of type I IFNs (Sato et al., 2000) 
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Upon activation, IRF-7 is translocated to the nucleus and forms complexes with 
other coactivators, such as IRF-3, NF-κB, C-Jun, activating transcription factor2, and 
p300/CREB-binding protein, to induce further transcription of type I IFNs (Honda et al., 
2005; Ning et al., 2011). Once in the nucleus, IRF-7 protein forms heterodimeric or 
homodimeric complexes with IRF-3, known as the virus-activated factor, however, IRF-
3 and IRF-7 act separately on type I IFN expression while complexed (Takaoka et al., 
2008; Yang et al., 2003). IRF-3, as well as IRF-7, are known to potently induce 
transcription of IFNβ in almost all cells while IRF-7, alone, preferentially induces IFNα 
expression in pDCs. (Hiscott, 2007b; Takaoka et al., 2008). There are conflicting studies 
suggesting IRF-7 protein can activate IFN transcription alone, without forming 
complexes with co-activators, however if this is correct, IFN response will be much 
weaker (Ning et al., 2011; Yang et al., 2003). IRF-7 expression is maintained, after 
initial activation of type I IFNs, through a positive feedback loop between active type I 
IFNs and IRF-7 (Ning et al., 2011). This positive feedback loop allows for continuous 
type I IFN expression until translational factors inhibit IRF-7 translation, removing the 
transcriptional stimulation of IFN. Despite normally expressed IRF-7 having antitumor 
effects, when overexpressed, IRF-7 can exhibit oncogenic properties and contribute to 
other autoimmune disorders such as rheumatoid arthritis (Ning et al., 2011). Proper 
regulation of IRF-7 is key to its success in maintaining proper IFN expression and 
combatting pathogens through the innate immune system.  
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IRF-7 Regulation 
IRF-7 expression initiates a robust cascade of IFN mediated responses and needs 
to be finely controlled by several unique and converging signals for proper activation 
and function. As the primary mediator of type I IFNs, a very restricted gene expression 
profile is critical for proper immune function. IRF-7 regulation can occur 
transcriptionally or translationally and is dependent on both viral infection and the 
presence of type I IFNs for proper activation (Hiscott, 2007a).  
Transcriptional regulation of IRF-7 is not well known but a recent study has 
shown that some transcriptional regulation occurs through transcription factors, nuclear 
co-repressors, and histone deacetylases. The FOXO family of transcription factors are 
known to assist in maintaining cell homeostasis by regulating gene expression associated 
with cell cycle control (Dejean et al., 2009). Transcription factor FOXO3 specifically 
has function in the immune system and suppresses basal IRF-7 expression, however, it 
does not have an effect on stimulated IRF-7 levels. In FOXO3 null murine macrophages, 
the absence of FOXO3 correlated with an increase in IRF-7 histone acetylation and thus, 
an increase in basal levels of IRF-7, unveiling its transcriptional regulation. 
Additionally, in these macrophages, binding of nuclear co-repressor 2 (NCOR2) and 
histone deacetylase 3 (HDAC3) binding to the IRF-7 promoter was reduced suggesting 
that FOXO3 plays a role in enabling other transcriptional regulators to bind to the IRF-7 
promoter (Litvak et al., 2012). Although transcriptional regulation of IRF-7 is 
understudied, it seems that translational regulation of this gene is more active and critical 
for proper function of IRF-7 in an anti-viral response.  
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The translation of mRNA to protein requires the formation of at least 9 
eukaryotic initiation factors (eiF) within the cell’s ribosome. These eiFs allow ribosomal 
subunits to attach to recycled post-termination complexes and form new complexes for 
translation, ultimately resulting in the 80S ribosomal initiation complex, which begins 
the translational elongation phase. Preceding the formation of the 80S complex, the 
mRNA is unwound at the cap region by the eiF4F complex, which activates the mRNA. 
Once the mRNA is activated, the 43S complex attaches to the activated mRNA and 
allows the 43S complex to scan the 5’ UTR and recognize the initiation codon within the 
A: Minimum free energy prediction of IRF-7 5’ UTR mRNA folding. B: Centroid 
prediction of IRF-7 5’ UTR mRNA folding. Four distinct stem loops are shown in both 
predictions which are hypothesized to be critical for translational factor binding (Kim 
et al., 2014). 
Figure 3: Predicted folding of the murine IRF-7 5' UTR (Kim et al., 2014) 
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mRNA.  Following these initiation steps, additional subunits are added to the 
translational complexes to form the 80S complex and allow for the elongation of 
polypeptide strands (Jackson et al., 2010). The complexity of translation initiation 
provides an opportunity for gene expression to be regulated at this step. Regulation of 
translation allows for rapid expression or repression of genes when the cell is under 
stress (Sonenberg and Hinnebusch, 2009). During cell stress, global translation is 
inhibited and the cell’s energy source goes into the rapid translation of genes needed to 
respond to such stress (Holcik and Sonenberg, 2005; Sonenberg and Hinnebusch, 2009). 
Cell stress caused by viruses complicate the cell’s translational response to the infection, 
since most viruses target the host cell’s translational mechanisms by either inhibiting 
translation or using the cell’s translational mechanisms for its own replication 
(Sonenberg and Hinnebusch, 2009).  In order to prevent the hijacking of the host cell’s 
translational mechanisms by viruses, it is critical that the cell recognize and respond to 
the virus rapidly, usually through the initiation of IRF-7 translation. 
IRF-7 is translationally regulated by features within its 5’ untranslated region 
(UTR), upstream of the translational start site. Translational factors, 2’-5’-oligoadenylate 
synthetase like 1 (OASL1) and 4E-binding protein 1 (4E-BP1), are two known potent 
regulators of IRF-7 translation. OASL1 is a member of the OAS family as well as an 
interferon stimulated gene (ISG). Though not well understood, OASL1 is thought to be 
induced by type I IFNs, viral and bacterial infection, lipopolysaccharide (LPS) 
stimulation, and IRF-3 (Guo et al., 2012; McNab et al., 2015; Zhu et al., 2015; Zhu et 
al., 2014). Although OASL1 has been shown to have anti-viral effects itself, it is known 
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to inhibit the translation of IRF-7 by binding to its 5’ UTR (Kim et al., 2014; Lee et al., 
2013). The predicted folding of the 5’ UTR RNA suggests 4 stem loops with 2 distinct 
single stranded regions which are assumed to be the binding sites of OASL1, Figure 3 
(Kim et al., 2014). Studies suggest that the binding of OASL1 to the IRF-7 5’ UTR 
inhibits the 43S complex scanning process from scanning the 5’ UTR and identifying the 
start codon, thus inhibiting its translation (Lee et al., 2013). 4E-BP1 is also an inhibitor 
of IRF-7 and is regulated by the phosphoinositide 3-kinase (PI3K) / mammalian target of 
rapamycin (mTOR) pathway. During type I IFN stimulation, the PI3K and mTOR 
pathways are initiated which phosphorylates and inhibits 4E-BPs from binding to eIF4E, 
allowing the association of eIF4E and eIF4G to occur as well as the activation of the 
mRNA for translation (Colina et al., 2008; Ning et al., 2011; Piccirillo et al., 2014). In 
contrast to the OASL1 inhibition of the 43S complex scanning, 4E-BP1 prevents the 43S 
complex from loading onto mRNA, also inhibiting the IRF-7 translation (Lee et al., 
2013; Sonenberg and Hinnebusch, 2009). The expression of 4E-BP1 is not affected by 
the innate immune response and therefore, its relative levels do not change during 
pathogen invasion. It is suggested that 4E-BP1 continuously inhibits IRF-7 translation 
during homeostatic conditions however, when the immune response stimuli becomes 
significantly heightened, the translational inhibition of 4E-BP1 is removed by its 
phosphorylation via mTORC1, allowing the dissociation of 4E-BP1 from the EIF4F 
complex, the association of eiF4E and eiF4G, the activation of mRNA, and thus, the 
translation of IRF-7 (Lee et al., 2013; Piccirillo et al., 2014). Together, OASL1 and 4E-
BP1 regulate the duration of type I IFN expression. Once the type I IFN signaling 
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pathways are underway and the cell is in an anti-viral state, OASL1 inhibits IRF-7, 
lowering the type I IFN response without silencing it. Once the innate immune system is 
down regulated and returning to a normal quiescent state, 4E-BP1 returns to its 
hypophosphorylated state and along with OASL1, completely and directly inhibits IRF-7 
translation and indirectly inhibits type I IFN transcription. 
Several studies have suggested how and where on the IRF-7 5’ UTR the 
translation inhibitory factor, OASL1, interacts. During previous studies in our 
laboratory, the porcine IRF-7 5’ UTR was truncated at different locations and cloned 
into a luciferase plasmid. A 129 base pair region at the 3’ end of the UTR was shown to 
be a critical regulatory element within the UTR as a whole, suggesting that the UTR 
RNA folding was crucial for IRF-7 regulation (Carvajal, 2014). In another study at 
Yonsei University, specific locations within the murine IRF-7 5’ UTR were targeted and 
truncated, then cloned into luciferase plasmids to measure OASL1 suppression of IRF-7 
(Lee et al., 2013). The authors suggested that OASL1 bound to stem loops present in the 
5’ end of the IRF-7 5’ UTR (Lee et al., 2013). IRF-7 is proven to increase the innate 
immune response and its 5’ UTR presents a unique target to enhance the innate immune 
response, however, unregulated overexpression of IRF-7 is not a viable option. The 
present work sought to better understand how IRF-7 is regulated by OASL1 in situ.  
Gene editing technologies were used to create modifications within the IRF-7 5’ UTR.  
Subsequently, immune system stimulation, transcript and protein levels of immune 
regulated genes measured at different time points. 
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IRF-7 has several functions in addition to type I IFN induction, such as activating 
proteins for antiviral, inflammatory, and pro-apoptotic functions as well as regulating the 
cell cycle and tumor suppression. Although IRF-7 is mostly known for these functions in 
the innate immune system, it has shown important function in the adaptive immune 
system as well. Macrophages transduced with active IRF-7 displayed enhanced tumor 
suppression abilities as well as an IRF-7 induced long lasting up regulation of IFN α and 
IFN β, effectively utilizing both the innate and adaptive immune systems to ward off 
invading viruses and unregulated cell division (Hiscott, 2007b; Romieu-Mourez et al., 
2006).  
Another interesting link between innate and adaptive immunity is that seen in 
plasmacytoid dendritic cells (pDC). These specialized dendritic cells produce larger 
amounts of IFN α than conventional dendritic cells. Viruses such as vesicular stomatitis 
virus reside in the endosomal compartment following infection which, in pDCs, is where 
CpG-A, a TLR9 ligand, resides along with MyD88-IRF-7 complexes (Honda and 
Taniguchi, 2006).  In conventional dendritic cells, CpG-A localizes in lysosomes and 
will not recognize these viruses.  The localization of CpG-A in the endosome of pDCs, 
allows for the initiation of TLR9 signaling, IRF-7 translation, and finally, IFN α 
transcription and secretion (Gabriele and Ozato, 2007; Hiscott, 2007b; Honda and 
Taniguchi, 2006). 
Recent studies have shown IRF-7 to suppress tumor formation through both the 
innate and adaptive mechanisms. In macrophages, IRF-7 can promote apoptosis in 
IRF-7 functions independent of IFNs 
19 
assisting with programmed cell death of tumor cells (Huang et al., 2009; Ning et al., 
2011). In another cascade, a tumor suppressor gene, BRCA1, can induce overexpression 
of IRF-7 which will inhibit the growth of certain breast cancer cells (Andrews et al., 
2002; Ning et al., 2011). 
Overexpression of IRF-7 
Despite the positive effects of IRF-7 on the innate immune response, its 
expression must be tightly controlled by the mechanisms described above. IRF-7 
overexpression has been shown to cause lymphomas when associated with Epstein-Barr 
virus (EBV) and its oncoprotein, latent membrane protein 1 (LMP1) (Ning et al., 2011; 
Zhang et al., 2004). Studies have suggested that LMP-1 and IRF-7 associate through a 
positive feedback loop where LMP induces IRF-7 activation and expression and the 
increase in active IRF-7 up regulates LMP-1 promoter activity, causing the formation of 
EBV associated tumors (Ning et al., 2011; Zhang et al., 2004).  
Due to its potent regulation and activation of type I IFNs, IRF-7 is hypothesized 
to have roles in autoimmune disorders such as rheumatoid arthritis and systemic lupus 
erythematosus (SLE) (Fu et al., 2011; Heinig et al., 2010; Ning et al., 2011). Future 
studies are needed to further understand the effects of overexpressed IRF-7, 
nevertheless, evidence suggests that proper regulation and control of IRF-7 is critical for 
proper function in both the innate and adaptive immune systems. 
Activated exogenous IRF-7 enhances immune response 
The recent discovery of IRF-7 as a master regulator of the type I IFN response 
macrophages through inducing the production of apoptotic ligands and subsequently 
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response. At the Plum Island Animal Disease Center, activated IRF-7/IRF-3 fusion 
protein in an adenovirus was used to inoculate pigs, which, after inoculation, were 
shown to be completely resistant to FMDV (Ramírez-Carvajal et al., 2016). In addition 
to using IRF-7/IRF-3 as protection against invading viruses, another study successfully 
used IRF-7/IRF-3 as adjuvants in vaccination. In an attempt to understand methods for 
plasmid DNA vaccinations, activated IRF-7/IRF-3 as adjuvants to a plasmid DNA 
vaccine were able to elicit protective immunity against E. coli β-galactosidase (Bramson 
et al., 2003). IRF-7 has been shown to be an effective agent in strengthening the host’s 
immune response however, exogenous IRF-7 cannot be regulated by the host properly. 
The lack of regulation and the negative effects of IRF-7 overexpression limits its use as a 
therapeutic agent. 
Proper IFN induction requires co-activator NF-κB 
In addition to the activation of IRF-3 and IRF-7 through TBK1, TLRs also 
initiate the transcription factor, nuclear factor kappa-light-chain-enhancer of activated B 
cells (NF-κB). This transcription factor, like IRF-7, has both MYD88 dependent 
signaling and MYD88 independent signaling. The MYD88 dependent pathway is 
triggered by the TLRs, with the exception of TLR3, recruiting MYD88 which promotes 
the activation of IKKα and IKKβ (Moynagh, 2005). These IKKs allow for the 
translocation of NF-κB to the nucleus where it stimulates the expression of co-
stimulatory molecules and proinflammatory proteins (Moynagh, 2005). For the MYD88 
independent pathway, TLR3 signaling activates NF-κB however, there are contradicting 
has led to research in the use of IRF-7 as a therapeutic agent to assist the host’s antiviral 
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2005). Due to the extreme similarity between the activation of IRF-3, IRF-7, and NF-κB, 
these transcription factors together maximize the type I IFN response to viral invasion. 
In addition to their synergistic effects NF-κB can also act as a regulator during 
autoimmune disorders for example, the absence of NF-κB during IRF-7 overexpression 
events prevents type I IFN response from being at its maximal level, minimizing the 
possible negative consequences associated with unregulated IRF-7 translation. 
Type I IFN Signaling 
Type I IFNs, specifically IFNα and IFNβ, are critical cytokines of the innate 
immune response and function to induce anti-microbial states to minimize viral 
replication, to regulate the innate immune response in promoting antigen presentation, 
and to activate the adaptive immune system, providing a robust response against 
pathogen invasion (Ivashkiv and Donlin, 2014). Basal levels of IFNβ are maintained by 
most cells in homeostasis which allows for the maintenance of IFNAR, JAK, STAT1, 
and IRF9 expression (Ivashkiv and Donlin, 2014). This miniscule expression keeps the 
cells primed for a rapid and robust IFN response to any pathogen that may invade 
(Ivashkiv and Donlin, 2014). Following the recognition of a pathogen and type I IFN 
activation by IRF-3, IRF-7, and NF-κB, type I IFNs initiate the signaling pathway 
responsible for creating the anti-viral state within the cell. Both IFNα and IFNβ are 
transcribed and bind to a heterodimeric receptor with components IFNAR1 and 
IFNAR2. However, IFNAR expression, ligation, and responses can be altered by the 
host’s environment, regulated by other signals outside the scope of this review (Ivashkiv 
studies about the mechanism by which NF-κB is activated in this pathway (Moynagh, 
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and IFNAR2 temporarily bind together and allow for the autophosphorylation of Janus 
kinase 1 (JAK1) and tyrosine kinase 2 (TYK2), for activation. (Darnell et al., 1994; 
McNab et al., 2015; Platanias, 2005). These kinases individually associate with the 
specific IFN receptor components; JAK1 with IFNAR2 and TYK2 with IFNAR1 
(Darnell et al., 1994; Platanias, 2005). JAK1 and TYK2 regulate the phosphorylation of 
signal transducer and activator of transcription (STAT) in the cytoplasm or in the 
nucleus, and when activated, the JAK-STAT signaling pathway is initiated (Platanias, 
2005).  
The activation of STAT is completely dependent on tyrosine phosphorylation 
and in this case, the IFN mediated dimerization of IFNAR allows for this to occur 
through autophosphorylated JAK (Darnell, 1997; Platanias, 2005). There are several 
STATs however, only STAT1, STAT2, STAT3, and STAT5 are directly affected by 
type I IFNs. STAT4 and STAT6 are activated in response to IFNα but only in lymphoid 
tissues (Platanias, 2005). In the classical pathway among non-lymphoid cells, STAT2 is 
the first to be phosphorylated in response to type I IFNS, following the activation of 
JAK, and STAT 1 activation is dependent on phosphorylated STAT2, resulting in a 
delayed stimulation of STAT1 (Darnell, 1997). STATI and STAT2 form DNA binding 
heterodimers, translocate to the nucleus, and can either directly initiate ISG transcription 
or form the ISGF3 complex with IRF-9 as mentioned earlier (Darnell, 1997; Platanias, 
2005). The ISGF3 complex is able to directly initiate ISG transcription by binding to 
IFN-stimulated response elements (ISRE) on ISG promoter regions and will also assist 
and Donlin, 2014). In the canonical pathway, upon the binding of type I IFNs, IFNAR1 
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Dissimilarly, most other cytokines induce the phosphorylation of STAT homodimers 
which bind to gamma activated sequences (GAS) to induce inflammatory responses 
(Ivashkiv and Donlin, 2014). 
Important regulators of genes needed for proper cellular functions are 
microRNAs (miRNA) and are still undergoing novel studies to completely understand 
their roles in several biological processes. The innate immune system signaling pathway 
is no exception and recent studies have both suggested and shown the importance of 
miRNAs for proper immune function. These miRNAs can not only inhibit viral 
transcripts, but can also increase the transcription of type I IFN signaling molecules such 
as STAT1, STAT2, and even IFNβ (Ivashkiv and Donlin, 2014). These miRNAs are IFN 
stimulated but can also be stimulated by other IFN stimulated molecules such as PRRs 
and proinflammatory cytokines (David, 2010; Ivashkiv and Donlin, 2014). Promotion of 
the immune system by miRNAs is important for the potency of IFN signaling as well as 
the inhibition of viral replication. 
Type I IFNs as effector molecules 
Type I IFNs have some direct affects including the control of gene expression. 
IFNα and IFNβ have been shown to increase major histocompatibility (MHC) classes I 
and II, as well as costimulatory molecules, which are necessary for antigen presentation 
to T-cells (Khabar and Young, 2007). This increase in MHC due to type I IFNs leads to 
an increase in macrophage activation, increased natural killer cell activity, and increased 
cytotoxic T-cell activity, beginning the activation of the adaptive immune system 
in IRF-7 induction to enhance the type I IFN response and antiviral response. 
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induces OAS expression which recognizes viral dsRNA and activates RNAse L for viral 
mRNA degradation (Khabar and Young, 2007). 
The type I IFNs not only induce the transcription of ISGs, but they have direct 
effects on the innate and adaptive immune systems as well, effectively bridging the gap 
between the two for a regulated, robust response. The IFNs can promote the expression 
of chemokine receptors, assisting in the dendritic cell migration as well as indirectly 
promoting T-cell activation. Type I IFNs can also promote IFNγ production, affecting T 
helper I cell (CD4) differentiation, survival and clonal expansion of cytotoxic (CD8) T-
cells (both effector and memory cells). Also through direct and indirect means, IFNα and 
IFNβ can promote NK cells as well as enhance B-cell responses (McNab et al., 2015).  
Despite the importance of type I IFNs in the innate immune system, with certain 
infections, IFNs can have negative effects on the host and even help in pathogen 
survival. In chronic viral infections, type I IFNs can cause immunosuppression and 
exacerbate the inflammation responses, causing tissue damage (Davidson et al., 2014; 
McNab et al., 2015). In acute viral infections, IFNs produced by myeloid cells increase 
apoptotic receptor expression on epithelial cells, contributing to host morbidity and 
mortality (Davidson et al., 2014; McNab et al., 2015). IFNα and IFNβ can also have 
detrimental effects on the host in responses to bacteria, fungi, and parasitic infections. 
Additionally, overexpression of type I IFNs either by unregulated IRF-7 or other stimuli, 
contributes to several autoimmune disorders such as SLE, Sjogren’s syndrome, systemic 
scleroses, myositis, and rheumatoid arthritis (Hall and Rosen, 2010; Ivashkiv and 
(Khabar and Young, 2007).  In another post transcriptional control mechanism, IFN 
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Donlin, 2014). The contribution that IFNs have on these disease states stresses the 
powerful effects of IFNs when not regulated properly or when being overstimulated.  
ISG activation 
 Type I IFN signaling is critical for inhibiting pathogen replication and translation 
however, IFNs are not the only active molecules that cause this inhibition. Once 
initiated, the IFN signaling cascade induces the transcription and the translation of ISGs, 
the main active molecules needed for pathogen inhibition and inducing the adaptive 
immune system.  
Type I IFN mediated ISG transcription is controlled by both the ISGF3 complex 
and the MAP kinase (MAPK) pathways. As discussed earlier, ISGF3 is a major complex 
that allows for the transcription of ISGs as well as phosphorylated STATs which bind to 
GAS regions. In addition to ISGF3, Type I IFN and the JAK/STAT pathway activates 
MAPK which controls the transcription of ISGs (Katsoulidis et al., 2005). MAPK 
activates p38 and together, they induce ISG transcription however, the exact mechanism 
is not defined and it is hypothesized that MAPK/p38 could affect chromatin remodeling 
of ISGs or may have effects on coactivators (Katsoulidis et al., 2005).  
In addition to transcriptional control of ISGs, IFNs also mediate translational 
regulatory pathways for ISGs. Phosphoinositide 3-kinase (PI3K)-AKT-mammalian 
target of rapamycin (mTOR) signaling is well-known for several other cellular functions 
however, in the innate immune system, this pathway inactivates translational suppressor 
eIF4E binding protein 1 complex as well as p70S6 kinase (Ivashkiv and Donlin, 2014; 
Lekmine et al., 2003). The p70S6 kinase phosphorylates 4E-BP1 which causes its 
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dissociation from eIF4E and inactivates 4E-BP1, allowing the translation of ISGs, 
specifically ISG15 and CXCL10, as well as IRF-7 (Joshi et al., 2010; Lekmine et al., 
2003). At this point, eIF4E forms a complex with eIF4G and together, they form a 
translation initiation complex to further increase translation of ISGs (Kaur et al., 2007). 
Additionally, MAPK interacting protein kinases (Mnk) 1 and 2 assist the p38/MAPK as 
well as the PI3K-AKT-mTOR signaling cascades in the phosphorylation and control of 
eIF4E (Joshi et al., 2010). Another direct target of type I IFNs to control ISGs translation 
is protein kinase RNA-activated (PKR) which inactivates eukaryotic translation 
initiation factor 2A, allowing for ISG translation and the inhibition of viral protein 
synthesis (Ivashkiv and Donlin, 2014; Khabar and Young, 2007). Although the ISG 
name implies that these genes are only induced by type I IFN pathways, new research 
has revealed that ISGs can be induced by subviral particles, dsRNA, single strand RNA 
(ssRNA), or other cytokines as well (Terenzi et al., 2006). 
ISG functions within the immune system 
There are a certain ISGs that have a tremendous effect on the host’s response to 
pathogens, especially viruses. ISG54 (IFIT2) and ISG56 (IFIT1) are very similar ISGs 
but have slightly different mechanisms. Both are induced by high levels of IFNβ, 
however, ISG56 is usually expressed in higher amounts and for longer periods of time 
than ISG54 (Terenzi et al., 2006). The protein products of ISG56 and ISG54, P56 and 
P54, bind to eiF3 to inhibit the translation of viral genes (Terenzi et al., 2006).  ISG56 
can also have a regulatory effect on IFN, blocking the cytoplasmic sensing of viral DNA 
and prevents IFN overexpression during an immune response (Yan and Chen, 2012). 
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Another important ISG, ISG15, is potently induced by type I IFNs, LPS, IRF-3, 
IRF-9, and NF-κB (Jeon et al., 2010). Once transcribed, ISG15 can regulate immune 
responses by inducing the secretion of IFNγ from B-cells and T-cells. It can also regulate 
signal transduction pathways, antiviral responses, as well as ubiquitination. ISG15 has 
an abundance of immune functions and when overexpressed, can also have oncogenic 
properties, so tight regulation must be in effect for ISG15 as well (Jeon et al., 2010).   
Myxovirus resistant protein 1 (MX1 in mice, MXA in humans) is one of the few 
ISGs directly expressed in response to type I IFNs (Haller and Kochs, 2010). MX1 is 
potently expressed in response to IFNα binding to its IRES component (Yuan et al., 
2015). MX1 is mostly known as a potent inhibitor of influenza viruses however, it is 
primarily an early block to viral replication of most viruses (Haller and Kochs, 2010).  
The 2’-5’ oligoadenylate synthase (OAS) family consists of 4 ISGs, OAS1, 
OAS2, OAS3, and OASL, however, OASL is also induced by IRF-3 (Kristiansen et al., 
2010; Melchjorsen et al., 2009).  OAS1 binds to dsRNA and ssRNA,, initiating OAS1 
activation and causes RNA degradation by inducing the RNase L pathway which inhibits 
protein translation in infected cells and prevents viral replication of pathogens 
(Kristiansen et al., 2010). Although most of the OAS family research has been done on 
OAS1, it is believed that this is the same mechanism for OAS2 and OAS3. Uniquely, 
OASL1 has an inhibitory effect on type I IFN response by its binding and regulation of 
IRF-7 as discussed earlier. Together with 4E-BP1, OASL1 prevents unregulated 
amounts of IRF-7 from being translated and thus, prevents the overexpression of type I 
IFNs and its cascade.  
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Genetic Engineering Using the CRISPR/Cas System 
In recent years, genetic editing technologies have become extremely popular 
among biologists and used to produce animals with targeted disease resistance. Although 
CRISPR is the most recent and popular tool currently, there have been animals produced 
with other technologies. In 2015, cattle with increased resistance to tuberculosis were 
produced using transcription activator-like effector nucleases (TALENs) (Wu et al., 
2015). Other researchers have used zinc-finger nickases (ZFNickases) to produce cows 
that secrete lysostaphin in their milk, presenting the ability to kill Staphylococcus aureus 
in the milk (Liu et al., 2013). Another research group in 2013, utilized both zinc-finger 
nucleases (ZFN) and TALENs to target REL associated protein (RELA), an oncogene 
associated with the immune system, and successfully produced live pigs with disease 
resistance (Lillico et al., 2013). At the University of Missouri, CD 163, a gene utilized 
by the PRRS virus in pigs, has been knocked out using CRISPR/Cas9 which resulted in 
animals that are completely resistant to PRRSV (Whitworth et al., 2016). These are just 
a few examples of successful gene editing projects focusing on disease resistance in 
livestock, however, these examples are targeted towards genes that are crucial for 
specific viruses and their survival. In order to provide an enhanced resistance to a 
broader range of pathogens and pathogen mutations, the regulators of the host’s immune 
system will need to be carefully and efficiently targeted by genetic editing mechanisms.   
Bacteria and archaea exhibit an adaptive immune defense against foreign DNA 
using clustered regularly interspaced short palindromic repeats (CRISPR). This system 
mediates immunity through three stages: adaptation, expression, and interference (Jinek 
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et al., 2012; Makarova et al., 2011). The first stage, adaptation, consists of the host 
copying the invading DNA in a fragment approximately 30 base pairs in size, upstream 
of a 3 base pair region known as the protospacer adjacent motif (PAM). In the 
expression stage, the repeat spacer element is transcribed into precursor CRISPR RNA 
(pre-crRNA) which is then cleaved into mature, short crRNAs which are ready to bind to 
complementary DNA regions. During the last stage, interference, the crRNA binds to 
complementary DNA regions on the invading DNA and the Cas9nuclease, part of the 
type II CRISPR locus, will cleave the double stranded DNA upstream of the PAM 
sequence (Jinek et al., 2012; Makarova et al., 2011). Several researchers have modified 
this system for gene editing in mammalian cells as well as in animals and have had 
tremendous success. Cong et al. have identified wild-type spCas9 nuclease which 
requires a PAM sequence in NGG format and causes double strand breaks (DSB).These 
DSBs are repaired by the cell’s DNA repair mechanism either by non-homologous end 
joining (NHEJ) or by homologous directed repair (HDR) (Cong et al., 2013). The 
current use of CRISPR for genetic editing in mammalian cells consists of producing a 20 
base pair spacer or protospacer, complementary to the target DNA directly upstream of 
the PAM region. A matured crRNA or tracrRNA is added and together with the 
protospacer, makes up the guide RNA (gRNA) which will recruit the Cas9 nuclease to 
the region of interest for cleavage (Cong and Zhang, 2015). Following a double strand 
break in the DNA, the cell’s repair machinery will effectively repair the break however, 
the CRISPR system will continue cleaving until a mutation within the guide targeted 
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region is generated and the gRNA can no longer bind, making this an extremely rapid 
and efficient gene editing system.   
With such robust technology, the ability to finely edit the 5’UTR of IRF-7 is 
achievable and will enhance the host’s innate immune response without causing 
overexpression issues. We hypothesize that finely editing the 5’ UTR of IRF-7 using 
CRISPR/Cas9 in porcine cells will allow for an enhanced innate immune response as 
well as provide more insight on the regulation of IRF-7 by 4E-BP1 and OASL1. This 
hypothesis will be tested by systematically deleting unique regions of the IRF-7 5’ UTR 
in SK6 cells and determine the effects on type I IFNs to pathogen recognition.  
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CHAPTER II 
MATERIALS AND METHODS 
CRISPR/Cas mediated modification of porcine IRF-7 5’ UTR 
IRF-7 RNA prediction and structure 
The IRF-7 5’ UTR sequence was determined by alignment to Sus scrofa 
expressed sequence tag (EST). The RNA folding predictions were performed using 
default folding parameters by an online RNA folding software, Vienna RNA Web Suite. 
Primers for polymerase chain reaction (PCR) were designed to target the porcine IRF-7 
5’UTR (appendix table 1) and used to create an amplicon of 796 base pairs (appendix 
table 2). Several PCRs were performed using CloneAmp HiFi PCR Premix (Takara, 
Mountain View, CA) and purified using Qiagen PCR Purification (Qiagen, 
Germantown, MD). The amplicon was sequenced at the Texas A&M Laboratory for 
Plant and Genome Technologies then compared to the sus scrofa EST database using the 
National Center for Biotechnology Information (NCBI) Blast program (appendix table 
2). Unfortunately, there are discrepancies between the NCBI annotation for the IRF-7 5’ 
UTR and the EST identified IRF-7 5’ UTR. RNA fold predictions were performed on 
both and gRNA design was based on homologous regions in both sequences.  
Guide RNA design and construction 
Guide sequences were designed in the IRF-7 5’ UTR after identification of PAM 
sequences for wild type Cas9 using Benchling online software (Benchling San 
Francisco, CA). On target and off target scores are based on Doench et al. and executed 
using the Benchling online software (Doench et al., 2016). The guide sequences as well 
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as their complements were ordered (Thermo Fisher Scientific Waltham, MA) as custom 
oligos with BbsI cut sites at the 5’ and 3’ ends and the guides, along with their 
complements, were denatured at 95°C and cooled to room temperature to allow for 
proper annealing as described by the Zhang lab (Ran et al., 2013). Guide RNAs were 
then cloned into a linearized pSpCas9(BB)-2A-GFP (PX458) plasmid containing a GFP 
expression insert, a gift from Feng Zhang (Addgene plasmid # 48138). Guide RNA 
cloning was confirmed by DNA sequencing at the Texas A&M Laboratory for Plant and 
Genome Technology using the LKO 1.5 primer sequence. Guide RNA sequences and 
oligo sequences can be found in appendix table 3.     
Cells and reagents 
Immortalized swine kidney cells (SK6) were originally provided by APHIS at 
Plum Island Animal Disease Center (PIADC), Greenport, NY. Frozen cell stocks were 
thawed and grown in media containing Dulbecco’s modified minimum essential media 
(DMEM) F12 and supplemented with 10% fetal bovine serum (FBS) (Atlanta 
Biologicals Flowery Branch, GA) and 1% antibiotic and antimitotic (Thermo Fisher 
Scientific Waltham, MA). Once cells were grown to approximately 90% confluency, 
cells were passaged using 1 X DPBS (Thermo Fisher Scientific Waltham, MA) and 
0.25% trypsin-EDTA (Thermo Fisher Scientific Waltham, MA). Cells were maintained 
in culture at 37°C in a humidified atmosphere of 5% CO2 and air.  
Preliminary guide RNA transfections and efficiency determination 
Cells were transfected with Cas9 plasmids, containing the appropriate target 
sequences, into 6 well tissue culture plates with Lipofectamine 3000 (Thermo Fisher 
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Scientific Waltham, MA) at 2.5 µg of DNA per well and incubated for 24 hours in 
normal tissue culture conditions. When needed, DNA was extracted from cells using a 
DNeasy blood and tissue kit (Qiagen Germantown, MD). To determine transfection 
efficiencies, GFP expression was visually analyzed 24 hours post transfection with a 
microscope equipped with UV fluorescence.   
During guide RNA construction, preliminary transfections were performed to 
determine functionality of each gRNA. This was achieved using the T7 Endonuclease 1 
assay (New England Biolabs Ipswich, MA) according to the manufacturer’s protocol. 
For cleavage detection, products from this assay were run on a 1.5% agarose gel at 60V 
for 3 hours. Amplicons for this assay were amplified using primers in appendix table 1. 
Primary gRNA transfections 
Once gRNAs were determined functional, SK6 cells were transfected in three 
different groups as seen in figure 4. Treatment group 1 was transfected with 3 of the 
most 5’ gRNAs. Treatment group 2 was transfected with 3 of the most 3’ gRNAs. 
Treatment group 3 was transfected with the most 5’ gRNA and the most 3’ gRNA in 
attempt to create a knockout. Additionally, a group of cells were transfected with Cas9 
plasmids which lacked the target sequence as unmodified controls. These unmodified 
cells underwent the same selection and handling processes as the cells transfected with 
target sequence containing plasmids, further known as unmodified-selected cells. 
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Illustration of the treatment groups used for the transfection of Cas9 plasmids containing target sequences (gRNAs) 
into SK6 cells. Multiple gRNAs were used in one treatment in attempt to produce several unique population 
modifications. 
Figure 4: Transfection treatment groups for the development of modified cell lines 
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Cell selection and clonal propagation 
Following primary transfections, cells were subjected to single cell sorting using 
the Texas A&M University Department of Pathobiology Flow Cytometry Core 
Laboratory. Cells were trypsinized as described previously and 1 x 106 cells were 
suspended in 1 mL of cold 1 X DPBS (Thermo Fisher Scientific Waltham, MA) 
supplemented with 10% FBS (Atlanta Biologicals Flowery Branch, GA), 1mM EDTA, 
and 1% antibiotic and antimicotic (Thermo Fisher Scientific Waltham, MA). Five µl of 
propidium iodide 1mg/mL (PI; final concentration 5 µg/ml) (Sigma-Aldrich St. Louis, 
MO) was added to the cell suspension. GFP positive and PI negative cells were sorted 
into 96 well plates with media containing 44% DMEM F12 (Thermo Fisher Scientific 
Waltham, MA), 45% FBS (Atlanta Biologicals Flowery Branch, GA), 10% conditioned 
media, and 1% antibiotic and antimitotic (Thermo Fisher Scientific Waltham, MA), 
further referred to as SK6 growth media. Sorted cells were incubated at 37o C in an 
atmosphere of 5% CO2, 5% O2, and 90% humidity.  
Interferon and ISG response in cells containing modified IRF-7 5’ UTR 
Poly I:C transfection  
Cells grown from single cell colonies and the non-clonal SK6 control were 
seeded in 12 well plates at a density of 0.2 x 106 cells per well. After 24 hours, cells 
were transfected with polyinosinic: polycytidylic acid (poly I:C) which is a synthetic 
analog of double stranded RNA (Invivogen, San Diego, CA) at 1 µg/mL using 
Lipofectamine 3000 (Thermo Fisher Scientific Waltham, MA), in SK6 growth media, 
for 8 hours at 37°C in atmospheric conditions of 5% CO2 and air. Cells were harvested 
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immediately after poly I:C treatment for RNA extraction using the Qiagen RNeasy Plus 
Mini Kit (Qiagen Germantown, MD).  
Analysis of mRNA expression by quantitative reverse transcription PCR 
Following poly I:C stimulation, RNA was harvested from the cell lines as 
described above. RNA was DNase treated using the Quantabio Perfecta DNase I kit to 
remove residual genomic DNA (Quantabio Beverly, MA). RNA was then reverse 
transcribed using the Quantabio qScript cDNA Supermix according to manufacturer’s 
protocol (Quantabio Beverly, MA). Reverse transcription PCR (RT-qPCR) was 
performed to evaluate expression of IRF-7, IRF-3, IFNα, IFNβ, 4E-BP1, OAS1, OAS2, 
OASL1, Mx1, ISG15, ISG54, ISG56 as well as GAPDH, HPRT, and TBP as reference 
genes for normalization, see appendix table 4 for primer sequences and efficiencies. 
Primer efficiencies were determined using standard curve quantification. Data analysis 
was performed using comparative quantification methods (Livak and Schmittgen, 2001). 
Statistics and data analysis 
  Statistical analysis was performed using GraphPad Prism 6, version 6.02. 
Data distribution was tested for normality using Shapiro-Wilk normality test and the 
Kolmogorov-Smirnov goodness of fit test. Data was determined to be non-Gaussian and 
thus analyzed using the non-parametric Kruskal-Wallis test along with a post hoc 
Dunn’s multiple comparisons test determine differences between each cell line including 
the unmodified cell lines. Alpha was set a priori at 0.05.   
 Due to variability among poly I:C stimulations and the magnitude of genes and 
cell lines originally tested, data was excluded from the results if any of the following 
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criterion was met: 1) Modified cell lines that did not consistently express Ct values 
below 32 for IFNβ under poly I:C stimulation and did not vary significantly from the 
unmodified selected cell line. 2) Biological replicates where the poly I:C stimulated Ct 
values for IFNβ in the unmodified-selected 1 cell line were 34 or above, which indicated 
a lack of stimulation. 3) The transcript levels of genes IFNα, 4E-BP1, ISG15, IRF-3, and 
IRF-7 expression did not differ significantly from the geometric mean of the reference 
genes therefore, they were not included in the reporting of the results. 
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CHAPTER III 
RESULTS 
CRISPR/Cas mediated modification of porcine IRF-7 5’ UTR 
5’UTR Sequencing 
The NCBI sequence for porcine IRF-7 5’ UTR was obtained through the 
University of California Santa Cruz (UCSC) Genome Browser. Primer sequences were 
designed to target the porcine IRF-7 5’ UTR and several hundred base pairs upstream of 
the predicted 5’ UTR. After a PCR was performed, the 796 base pair amplicon was 
sequenced and analyzed with the NCBI Blast program within the EST database. Due to 
an incomplete annotation of the porcine genome, the sequence obtained from the 796 bp 
amplicon allowed for the identification of the proper EST sequences associated with 
IRF-7. The sequence generated from the amplicon extends 140 base pairs upstream of 
the EST sequence and 196 base pairs downstream and into the coding sequence of IRF-7 
leaving 305 base pairs in between, assumed to be the 5’ UTR.  The 305 base pair EST 
sequence that was obtained was aligned to the NCBI annotated 5’ UTR which indicated 
that the 5’ UTR EST was 94 base pairs larger than the NCBI annotated 5’ UTR, figure 5. 
Individual sequences for the 796 base pair amplicon, the NCBI annotated sequence, and 
the EST sequence can be found in the appendix. 
 
 
 39 
 
 
Illustration of the 796 base pair amplicon aligned with the previously known NCBI annotated 5’ UTR and a matched 
EST sequence. The genomic amplicon extends beyond what is recorded in NCBI databases. 
Figure 5: Amplified genomic sequence of porcine IRF-7 
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Guide RNA Design 
 Twice, gRNAs were synthesized to target 6 different regions throughout the 
porcine IRF-7 5’ UTR which mapped to both the NCBI annotated sequence and the EST 
sequence. Twelve gRNAs were successfully cloned into the PX 458 plasmid and 
confirmed by DNA sequencing (figure 6 and appendix table 1).  
 
 
 
 
 
 
 
 
 
Guide RNA Subcloning 
 In preliminary experiments, SK6 cells were transfected with plasmids containing 
the gRNAs individually to determine guide functionality. The SK6 cell transfections 
resulted in a 60-70% transfection efficiency, as determined by visual assessment of GFP. 
Unknown issues caused the first gRNA design to fail, as discussed in the next section, 
Guide RNAs were designed to target different regions among the whole NCBI 5’ UTR 
sequence. The orange arrows indicate the location of the gRNAs to the 5’ UTR 
sequences as well as the direction of the gRNA. 
Figure 6: Guide RNAs designed to target 6 unique locations within the IRF-7 5’ UTR 
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and 6 more guides were designed and subcloned into PX 458, their homologous 
locations in the 5’ UTR are shown in figure 6. 
Guide functionality and efficiency 
 Following successful transfections and cell harvesting, DNA was extracted from 
a mixed population of cells in a single treatment and the T7 Endonuclease 1 assay was 
performed. The first preliminary transfections and T7 Endonuclease 1 assay did not yield 
cleavage bands indicating that the first set of guides were either not functional or not 
efficient. The second preliminary transfections with new gRNA designs yielded 
successful transfections and T7 Endonuclease 1 assay, figure 7.  Guides 2,3, and 6 were 
proven to be functional through the presence of cleavage bands as seen below, however, 
guide 1 may have created a large insertion, causing the multiple bands seen above and 
below the parent band. Although 2 gRNAs did not show cleavage bands, they may still 
be functional but with a low efficiency, therefore, all six guides were used for modified 
cell line development. 
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Guides 2,3, and 6 displayed cleavage bands indicating a positive modification to cells. Guide 1 may 
have caused a large insertion, causing the large band above the brighter parent band. Guide RNAs 3 and 
4 did not produce cleavage bands but may have low efficiency causing the T7 endonuclease to not 
recognize mismatched DNA. Guide RNAs 1,3, and 4 were confirmed to produce deletions through 
single cell sorting and sequencing. Red boxes indicate the cleavage bands visible at high exposure. 
Figure 7: Four gRNAs caused cleavage bands in the gel electrophoresis of a T7 Endonuclease 1 assay 
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Modified cell line development 
 SK6 cells were transfected with a combination of gRNAs to induce several 
unique mutations within a small region of the 5’ UTR. The treatment groups consisted of 
cells transfected with gRNAs 1,2, and 3 (G1-3), gRNAs 4,5, and 6 (G4-6), and gRNAs 1 
and 6 (G1&6). As a control for clonal cell selection, SK6 cells were transfected with a 
PX458 plasmid lacking a gRNA and were subjected to the same selection processes as 
the cells transfected with gRNAs. Twenty-four hours post transfection, the cells were 
sorted by GFP expression directly into 96-well plates to form single cell colonies. Cells 
were grown and expanded until they reached confluency in 48 well plates, which then, 
12 cell lines per treatment group were selected for further culture and the rest were 
frozen and stored.  
 DNA was extracted from the cells selected for culture and each cell line was 
sequenced for mutation analysis. The transfection and selection process resulted in a 
total mutation rate of 82%, of which 41% of those mutations were unique.  
Within the first treatment group, 8 out of 12 lines survived and 6 of those 8 cell 
lines were positive for a modification. Of the positive cell lines, 5 out of 6 had mixed 
populations of cells, with either a modified line mixed with a wild type line or with 
another modified line. These mixed population cells were diluted and re-grown from 
single cells in attempt to isolate individual mutations. In two of those diluted cell lines, 
modifications were identified, isolated, and analyzed. Altogether, 5 cell lines with 
modifications were isolated and only three unique deletions were observed.  
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All 12 cell lines within the second treatment group survived and yielded 7 
modified lines, with only 1 line having a mixed population. The modification in the 
mixed population cell line could not be isolated. Altogether, 6 deletions were observed 
and 5 of those were unique.  
The third treatment group yielded 11 surviving cell lines with 7 of those being 
modified. Two of those lines had mixed populations and 1 line was successfully isolated 
and its modification analyzed. Of the seven modified lines one line had a 360 base pair 
deletion that included part of the IRF-7 coding sequence. Another line resulted in a 191 
base pair deletion, our closest modification to a knockout. This treatment yielded 6 
deletions but also had one line with an insertion. A summary of each cell line’s 
modification is listed in table 1. 
Eight unique modifications were used for the quantification of innate immune 
response. With a total of 10 cell lines, 2 modifications were repeated in different cell 
lines to provide internal controls for clonal selection variation. These modifications are 
illustrated in figure 8.  
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Treatment Colony ID Population Base Pair Change Modification Type Guides in Modification Location
1: G1-G3 1A Mixed 1,2,3
2A Mixed
2.2 Single -from mixed 43 & 5 Deletion 1-2 and 3 -202 to -159 and -130 to -125
2.5 Single -from mixed 28 Deletion 2,3 -160 to -132
2.6 Single -from mixed 43 & 5 Deletion 1-2 and 3 -202 to -159 and -130 to -125
6A Single Wild type
7A Mixed
7.1 Single -from mixed 28 Deletion 2,3 -160 to -132
8A Mixed
9A Single 72 Deletion 1,2,3 -202 to -130
10A Mixed
2: G4-G6 1A Mixed
2A Single 83 Deletion 4,5,6 -94 to -11
3A Single Wild type
4A Mixed
5A Single 83 Deletion 4,5,6 -94 to -11
6A Single 42 Deletion 4,5,6 -92 to -50
7A Single 40 Deletion 5,6 -50 to -10
8A Mixed
9A Mixed
11A Single 82 Deletion 4,5,6 -93 to -11
12A Single 82 Deletion 4,5,6 -93 to -11
3: G1 & G6 1A Single Wild type 
2A Single 191 Deletion 1,2,3,4,5,6 -203 to -12
3A Mixed
4A Mixed
5A Mixed
6A Mixed
6.6 Single -from mixed 5 Deletion 6 -12 to -7
7A Single Wild type
8A Mixed 6
9A Single Wild Type
10A Single Wild Type
11A Single 360 Deletion 1,2,3,4,5,6 -202 to +157
Table 1: CRISPR/Cas9 system induced modifications in 82% of sequenced cell lines 
 
 
 
 
Population type, modification type, base pair changes, and their locations are listed for each cell line. Location 
is based on the translational start site as 0.  
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The different treatment groups resulted in an array of unique deletions within the 
gRNA target region. 
Figure 8: Deletions within the IRF-7 5’ UTR ranged from 6 base pairs to 191 base 
pairs  
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RNA Folding predictions of the modified cell lines’ IRF-7 5’ UTR  
 The IRF-7 5’ UTR sequences for each modified cell line were entered into the 
Vienna Websuite RNAfold WebServer for prediction of RNA folding. Although the 
program predicts folding in both minimum free energy (MFE) and centroid algorithms, 
the folds presented here will be from the MFE algorithm. The wild type IRF-7 5’ UTR 
structure yields four distinct stem loops as seen in tables 2A and 3A, similar to the 
murine model. Most of the modified cell lines maintained 4 stem loops with the 
exception of 4 lines. In treatment 1, SK -160/-132 (table 2C) had a reduced stem loop, 
bound to stem loop 3. Also SK -202/-130 (table 2D) completely lost a stem loop. SK -
203/-12 (table 3F) seemed to have only two stem loops and is much smaller than the 
other structures.  
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Figure 9: CRSPR/Cas9 induced deletions altered the predicted secondary 
structures of the IRF-7 5’ UTR 
s 
A. 
Wild Type  
350 Base Pairs 
 
B. 
SK -202/-159 and -130/-125 
157 Base Pairs 
 
C.  
SK -160/-132 
177 Base Pairs 
 
D.  
SK -202/-130 
133 Base Pairs 
 
The MFE algorithm was used to predict the RNA folding of the wild type 5’ UTR and 
the 5’ UTR of modified cell lines. Stem loops are numbered from the 5’ end. In C and 
D, stem loop 2 is either diminished or missing.   
Base Pair Probabilities 
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E. 
SK -94/-11 
222 Base Pairs 
 
F.  
SK -62/-50 
263 Base Pairs 
G.  
SK -50/-10 
265 Base Pairs 
 
 
H.  
SK -93/-11 
223 Base Pairs 
I. 
SK -203/-12 
114 Base Pairs 
 
J.  
SK -12/-7 
300 Base Pairs 
Figure 9 Continued 
 
 
 
Modified cell line IFN stimulation 
Poly I:C stimulation and gene expression 
 Originally, 13 cell lines were tested, 10 modified and 3 not modified. The 3 wild 
type cell lines consisted of 2 unmodified cell lines that were originally transfected with 
the empty Cas9 plasmid then subjected to selection and clonal expansion along with the 
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cell lines transfected with Cas9 plasmids containing target sequences, referred to as 
unmodified-selected 1 and 2. The third unmodified cell line originates from cells that 
were not transfected with a Cas9 plasmid nor were they subjected to selection or clonal 
expansion, referred to as non-selected.  
 After 3 preliminary biological replicates, modified cell lines that did not 
consistently express Ct values below 32 for IFNβ under poly I:C stimulation and did not 
vary significantly from the unmodified selected cell line, were excluded from statistical 
analysis and further biological replicates. Treatment 1 cell lines that fell under this 
exclusion were SK-202/-159 and SK-130/-125 and SK-160/-132. Modification -160/-
130 was duplicated in two different cell line populations. One of these lines, was 
excluded from results. All of treatment 2 cell lines (SK-94/-11, SK-92/-50, SK-50/-10, 
SK-93/-12) were excluded along with cell line SK-203/-12. Additionally, IFNα, 4E-BP1, 
ISG15, IRF-3, and IRF-7 expression did not differ from the geometric mean of the 
reference genes (data not shown).  
 Due to variation in poly I:C stimulation between biological replicates, biological 
replicates where the poly I:C stimulated Ct values for IFNβ in the unmodified-selected 1 
cell line did not go below 34, indicated a lack of stimulation and were excluded. 
Following the exclusions, 3 biological replicates, 3 modified cell lines, and 10 genes 
were used in analysis. Modified cell lines included were SK-160/-132 and SK-202/-130, 
as well as SK-12/-7. Genes that were included in that analysis were MX1, OAS1, OAS2, 
ISG54, ISG56, IFNβ, and OASL. Data gathered was tested for normality and was 
determined to be non-Gaussian, figure 9, therefore, the non-parametric Kruskal-Wallis 
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test along with a post hoc Dunn’s multiple comparisons test was used for statistical 
analysis.  
 
 
 
  
 
 
 
To understand variation due to selection and clonal expansion, the two 
unmodified-selected cell lines’ immune response gene transcript levels were compared 
to the non-selected SK6 cells transcript levels and no differences were determined, 
 
Data from each cell line was determined to be non-Gaussian by the D’Agostine & 
Pearson omnibus normality test, the Shapiro-Wilk normality test, and the 
Kolmogorov-Smirnov goodness of fit test.    
Figure 10: Collected data failed tests for normality 
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figure 9. Additionally, non-stimulated ΔCt values for ISGs and IFNβ were compared 
among cell lines to determine if cell line modifications altered baseline levels of 
interferon and interferon stimulated genes. Significant differences were not detected 
between cell lines indicating that the 5’ UTR modifications did not alter baseline gene 
expression, figure 10.   
 
 
 
 
  
Figure 11: Selection and clonal propagation of SK6 cells does not alter gene 
expression profiles. 
Selected and clonally expanded cell lines (Unmod Sel 1 and 2) were compared to not 
selected, wild type SK6 cells. No difference was observed in immune regulated gene 
expression between the unmodified selected cells and the wild type SK6 cells which 
indicates that there was not a difference in gene expression due to the selection and 
expansion process.   
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The fold change, ΔΔCt values, in gene expression following stimulation with 
poly I:C was compared in 3 modified cell lines and an unmodified control. SK -202/-
120, had a consistent and significant heightened immune response than the unmodified 
selected cell line in all 7 genes, figure 11. SK -160/-132, only showed an increase in 
OASL expression (p<0.05), figure 11. These two cell lines indicate that the 5’ UTR 
modifications do alter the immune responses to poly I:C stimulation. SK -12/-7 had 
some upregulation however, it was not significantly above the unmodified selected cell 
line, figure 11.   
Modified cell line baseline gene expression were compared to each other and an 
unmodified selected cell line. The lack of statistical significance indicates that the 
IRF-7 5’ UTR modifications do not alter baseline gene expression when the immune 
system is not stimulated.  
Figure 12: Genetic modification of the IRF-7 5' UTR does not alter unstimulated 
gene expression 
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SK -202/-130 gene expression was significantly increased compared to the unmodified 
selected cells among all 7 genes. SK -160/-132 exhibited a significant increase in only 
OASL expression. However, SK -160-132 tended to have an increased response in 
genes MX1, OAS1, and ISG54 (p ≤ 0.11). SK -12/-7 was not different from 
unmodified selected cells. * p < 0.05   
Figure 13: Specific cell lines have increased response to poly I:C. 
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CHAPTER IV 
DISCUSSION 
The translational regulation of IRF-7 has been heavily studied since its discovery 
in 2005 as the master regulator of type I IFNs. Despite the numerous studies, the exact 
method and pathway for its regulation still remains a mystery. Each study has continued 
to enhance our knowledge of IRF-7 regulation in a very specific manner. Currently, two 
translational factors, OASL and 4E-BP1, are known to regulate IRF-7 through the 
secondary structure of its 5’ UTR, however, the specific location of that regulation and 
how the secondary structure of the 5’ UTR interacts with regulatory factors remains 
unknown. The discovery and optimization of the CRISPR/Cas9 gene editing system has 
now offered an opportunity to understand the location and structure needed for 
regulation. 
 The CRISPR/Cas9 system is known for its efficient and specific gene editing 
capabilities. The results from designing the gRNAs, testing gRNA efficiency, and from 
the development of the modified cell lines reinforces its use as a robust gene editing tool. 
Despite its efficiency, the CRISPR system is not perfect. Especially in cell lines, the 
system is known to produce off-target effects, where the gRNA initiates cleavage and 
possibly the modification of DNA regions outside of the region of interest. Current 
bioinformatics programs are not completely efficient at determining off-target effects 
and are still being optimized. Due to the incomplete and poorly annotated porcine 
genome, off target effects were not analyzed for this project.  
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 Despite the limitation of determining off target effects, there were conflicting 
results from data gathered in this project. Two cell lines exhibited the exact same 
mutation -160/-132 but yielded different results. One cell line had a much more robust 
and potent response to poly I:C than the other. In fact, the low responding cell line was 
excluded from the results due its response not varying from the unmodified cell lines. 
Possible explanations for this could be that the low responding cell line had off target 
mutations, inhibiting its response to poly I:C. Another explanation could be that the 
selection and clonal expansion process induced an alteration in gene expression, which 
repressed response. Despite this issue, other cell lines revealed upregulation following 
stimulation of the innate immune response.  
SK -160/-132 and SK -202/-130 resulted in surprising insights into the location 
of IRF-7 regulation. A study performed at our lab in 2014 using a luciferase plasmid and 
truncated IRF-7 5’ UTR suggested that the most 3’ region of the 5’ UTR was critical for 
regulation however, the data from this study suggests otherwise (Carvajal, 2014). The 
most robust and significant upregulation of the immune response was obtained in SK -
202/-130 which had its modification in the 5’ region of the UTR and altered the 
predicted secondary structure by the elimination of one stem loop and the reduction stem 
loop size when compared to the wild type folding and cell lines with modifications in the 
more 3’ region of the UTR. Although SK -160/-132 only demonstrated significant 
upregulation in OASL when compared to the unmodified-selected cells, it still tended to 
have an increase in response however, it was not as robust as SK -202/-130. OASL, a 
product of IFN stimulation, is evidence of an increase in the innate immune system. 
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When considering the 5’ UTR RNA folding, SK -160/-132 had a greatly reduced stem 
loop sizes and, similar to SK -202/-130, had 3 major stem loops. The reduction in stem 
loop size may have caused the upregulation of IRF-7 protein leading to a small increase 
in IFNβ causing a significant increase in OASL1 gene transcript levels in response to 
poly I:C stimulation. It cannot be speculated exactly what factor is regulating IRF-7 in 
SK -160/-132 but there does seem to be more translational regulation of IRF-7, possibly 
by translational factors 4E-BP1 and OASL1, in the cell line than in SK -202/-130. 
Interestingly, a 2013 study on the interaction between OASL and the IRF-7 5’ UTR, 
through dual luciferase assays, indicated that UTR modifications specifically altering the 
first or second stem loop altered the suppressive ability of OASL1, whereas 
modifications in the third and fourth stem loops retained OASL suppression (Lee et al., 
2013). Although the current study did not target specific stem loops, the results confirm 
that the stem loops in the 5’ end of the IRF-7 5’ UTR may be more critical for 
translational factor regulation than stem loops in the 3’ region. 
 Two other modified cell lines resulted in the reduction of stem loop size. SK -
202/-159 and -130/125 has stem loop size reduction in two stem loops, however, that 
cell line did not display an increased immune response.  SK -203/-12 was the closest to a 
5’ UTR knockout that was generated. Although its folding lacks 2 stem loops, it did not 
exhibit in increased expression of innate immune regulated genes either. The immune 
regulated gene transcript levels for this cell line did not differ from the unmodified cell 
lines, indicating that transcription was neither inhibited nor promoted. It is possible that 
the deletion resulted in the loss of a critical region for promoting translation of IRF-7, 
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resulting in no change to ISG and IFNβ transcript levels. However, since the ISG and 
IFNβ transcript levels were not significantly lower than in the unmodified cells lines, the 
-203/-12 modification did not completely inhibit expression of IRF-7.  
 Modifications in cell lines with modifications in the 3’ region of the UTR did not 
alter the amount of stem loops. Minor modifications of the structure and its organization 
are seen however, that reorganization did not seem to have an effect on gene expression. 
This further solidifies the assumption that the translational factors do not bind to specific 
sequences, but to certain stem loops. Although increased immune responses were not 
shown with modifications to this region, it should be noted that this should remain a 
region of interest since deletions in this region may still reduce stem loop numbers. 
 Although there have been several studies to understand IRF-7 regulation, two 
translational factors have been found as key regulators, 4E-BP1 and OASL1. A study 
mentioned earlier by Lee et al. in 2013, sought to determine the role of OASL1 in IRF-7 
regulation. The researchers produced fragments of the murine IRF-7 5’ UTR and used a 
dual luciferase assay to determine where OASL1 repressed IRF-7 translation. By 
directly targeting sequences in the stem loop structures, they found that the removal of 
the first and second stem loops of the 5’ UTR significantly reduced the suppressive 
abilities of OASL1 on IRF-7 translation (Lee et al., 2013). With this information, it can 
be hypothesized that the destruction of the wild type secondary structure in the present 
study inhibits OASL1 regulation. Additionally, the lack of change in baseline, non-
stimulated immune response gene transcripts between modified cell lines and the 
unmodified selected cell line can be used to assume that regulation of IRF-7 translation, 
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while the innate immune system is in a quiescent state, is still occurring, possibly by 4E-
BP1. The 4E-BP1 inhibition is removed from IRF-7 once there is a potent increase in 
IFN levels and it is assumed that the ability of OASL1 to down regulate the immune 
response is important for allowing 4E-BP1 to once again inhibit IRF-7 (Colina et al., 
2008; Lee et al., 2013; Ning et al., 2011). If in fact the elimination of stem loops in the 
IRF-7 5’ UTR secondary structure inhibits IRF-7 translational regulation by OASL1, it 
may be difficult for the cell to gain appropriate control of IRF-7 translation for 4E-BP1 
to once again bind and inhibit IRF-7. This may lead to an overactive immune system, 
possibly causing autoimmune disorders, unless there is another inhibitor of IRF-7 that 
will assist in down regulating the immune response. Future experiments examining the 
chronological control of this pathway would help address this issue. More studies should 
be done measuring the immune response in modified cell lines at different time points 
after the removal of stimulus.   
 Overall, the data suggests that all four stem loops are critical for IRF-7 
translational regulation. With more studies in these regulatory regions, a more in depth 
knowledge of IRF-7 translational regulation can be achieved. The current project will be 
continued and secreted IFNβ levels will be measured by enzyme linked immunosorbent 
assay (ELISA) and cellular IRF-7 protein levels, both phosphorylated and 
unphosphorylated, will be determined by western blot to further understand IRF-7 
regulation.  
 More studies are needed for a complete understanding of this system. Future 
studies could use homologous directed repair (HDR) with CRISPR/Cas9 to finely edit 
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regions to reduce or eliminate stem loop structure. Although luciferase assays with 
modified IRF-7 5’ UTRs have been done previously, using CRISPR and gene expression 
analysis will provide a more accurate representation of interactions between translational 
factors and the 5’ UTR in vitro. Once the regions of regulation are determined, an animal 
model could be produced with IRF-7 5’ UTR modifications specifically aimed towards 
the regulatory stem loops, which the animals can then be immunologically challenged 
and their immune responses analyzed. Such studies can lead to a deeper understanding 
of the IRF-7 gene and its regulation, which can be used to produce animals with more 
efficient immune responses to viruses and even unveil a genetic target for 
pharmacological substances to enhance the immune function in humans.   
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APPENDIX  
Primer Name Primer Sequence 
IRF-7 UTR Fw ACGAAACTTCCTGCCCCG 
IRF-7 UTR Rev GGAACCGTGTTCTGGCTTCA 
 
Appendix Table 1: Primers used for amplification of genomic DNA surrounding the porcine 
IRF-7 5’ UTR region. Amplicon sequence is listed in appendix table 1. 
 
 
 
 
 
 
 
 
Appendix Table 2: IRF-7 5’ UTR sequences  
  
Source IRF-7 5’ UTR Sequence 
NCBI Annotated TCACCTGGGCAACGTCGTGGCCAGAGCCCTCAACCCCCATCTGTGAC
CCCAACACCCGTGACACCTGGCCACACTCACTACCTGTGGTGTGTGG
TGACACACGCGCAGCTCTCCTCTCACCTGCGGTTAACACCTGCCTGC
CCCCGTGGTCAGAGCTCTCGCCGCGGAGGCCAAGCCAGTGTCTCCAC
GCCCAGTCCTTGCAGAGGGAGCA 
Expressed Sequence 
Tag 
CAGGGCCCATCCCGGGCGCCAGCTCGACACCTGTGGCCCCTGTGCGC
CCGCCCTCCACGTCTGCAGTCACGCCCATCGCCGCCTTGGCCAAGAC
TCACCTGGGCAACGTCGTGGCCAGAGCCCTCAACCCCCATCTGTGAC
CCCAACACCCGTGACACCTGGCCACACTCACTACCTGTGGTGTGTGG
TGACACACGCGCAGCTCTCCTCTCACCTGCGGTTAACACCTGCCTGC
CCCCGTGGTCAGAGCTCTCGCCGCGGAGGCCAAGCCAGTGTCTCCAC
GCCCAGTCCTTGCAGAGGGAGCA 
796 Base Pair 
Amplicon 
CCATCTGGTATGGGGACCCCACCTACGCGGAGCGAGAGGGGCAGGG
ACGGCCACGTCGGATCCCGGGTTCGCTTCGCAGAGCAGTGACCAGCA
GGGGGCGGGCAGCGCGGGTGACTGCGGGGGGAGGGGCACGGGTCC
GGAATTGGGGAACCTGGAGGCAGAGGTCGCGGTTGCCGAGGACGAG
CCGGGCGGGCGGGGCAGGGAGGGGGCGCCGGCCGCCCCGCGGCCCA
GCTGGTTAGGTTTCGTTTTCCTGCGACACGCGGTTTCGTTTCCTTGCG
GTCGTCGCGCCCCCGCAGGGCCCATCCCGGGCGCCAGCTCGACACCT
GTGGCCCCTGTGCGCCCGCCCTCCACGTCTGCAGTCACGCCCATCGC
CGCCTTGGCCAAGACTCACCTGGGCAACGTCGTGGCCAGAGCCCTCA
ACCCCCATCTGTGACCCCAACACCCGTGACACCTGGCCACACTCACT
ACCTGTGGTGTGTGGTGACACACGCGCAGCTCTCCTCTCACCTGCGG
TTAACACCTGCCTGCCCCCGTGGTCAGAGCTCTCGCCGCGGAGGCCA
AGCCAGTGTCTCCACGCCCAGTCCTTGCAGAGGGAGCAATGGCCGCG
GCTCCTGACAGGTGACAGCCCGCAGCCCTACCCGGTGCCAACCCCAA
GCACCTCGCGGTCCGCGCGTGCCCTGACGCCCGCTGCTCTGCCCGCA
GGGGGTGCCCACGCGTGCTCTTCGGAGACTGGCTTCTGGGCGAAGTC
AGCAGCGGCCGTTACGCAGGGCTGCGATGGCTGGATGAAGCAGACC
CC 
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Guide 
RNA 
Guide Sequence Forward Oligo Reverse Oligo 
1 CTCTGGCCACGACGTTG
CCC 
CACCGctctgtccacgacgttgcc
c 
aaacgggcaacgtcgtggacagag
C 
2 GCCAGGTGTCACGGGTG
TTG 
CACCgccaggtgtcacgggtgttg aaaccaacacccgtgacacctggc 
3 CTGGCCACACTCACTAC
CTG 
CACCGctggccacactcactacct
g 
aaaccaggtagtgagtgtggccag
C 
4 AGGTGTTAACCGCAGGT
GAG 
CACCGaggtgttaaccgcaggtga
g  
aaacctcacctgcggttaacacctC 
5 CGTGGTCAGAGCTCTCG
CCG 
CACCGcgtggtcagagctctcgcc
g 
aaaccggcgagagctctgaccacg
C 
6 CCACGCCCAGTCCTTGC
AGA 
CACCGccacgcccagtccttgcag
a 
aaactctgcaaggactgggcgtgg
C 
 
Appendix Table 3: Guide RNA sequences and oligo sequences.  
Capitalization in oligos indicate added base pairs for restriction enzyme cut sites and for cloning 
optimization. 
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Appendix Table 4: RT-qPCR primer sequences, efficiencies, and references. 
Gene Direction Sequence Amplicon 
Size 
Efficiency R2 Genbank 
Reference 
Literature 
Reference 
GAPD
H 
Fw CAAGGAGTAAGAGCCCCTG
G 
123 92% 0.99 NM_001206
359.1 
 
Rev AGTCAGGAGATGCTCGGTG
T 
HPRT Fw GGACTTGAATCATGTTTGT
G 
91 100.5% 0.99 DQ845175 (Nygard et 
al., 2007) 
Rev CAGATGTTTCCAAACTCAA
C 
   
TBP Fw AACAGTTCAGTAGTTATGA
GCCAGA 
153 109.9% 0.99 DQ845178 (Nygard et 
al., 2007) 
Rev AGATGTTCTCAAACGCTTC
G 
    
OAS1 Fw CTGTCGTTGGACGATGTAT
GCT 
66 89.9% 0.99 AJ225090 (Diaz-San 
Segundo et 
al., 2010) Rev CAGCCGGGTCCAGAATCA 
OAS2 Fw CCCTGGACCTATCGAGACC
T 
132 137% 0.97 NM_001031
796.1 
 
Rev TGAAACCGCCAGCTTTTCC
T 
     
4E-
BP1 
Fw TGTGACCAAAACGCCCCCG
A 
150 124% 0.97 NM_001244
225.1 
(Carvajal, 
2014) 
Rev AACTGTGACTCTTCACCGC
CCG 
    
ISG15 Fw CTGGAGGGTGGGGAGGGT
AG 
84 103% 0.95 ENSSSCT00
000029764 
(Wilkinson 
et al., 2015) 
Rev GTCCCAGGGCCACCACATA
G 
    
IRF-3 Fw CATGGACTTGGCCTCGGAT
G 
169 151% 0.95 NM_213770.
1 
 
Rev GAACTCCCACTCGTCGTCA
T 
    
IRF-7 Fw TCGTGATGTTGCAGGACAA
CTC 
110 104% 0.99 HQ026022.1 (Wang et al., 
2010) 
Rev CTCTTCCCCCGGGTTGAA     
ISG54 Fw CTGGCAAAGAGCCCTAAGG
A 
104 118% 0.98 NM_001315
658.1 
(Wang et al., 
2010) 
Rev CTCAGAGGGTCAATGGAAT
TCC 
    
ISG56 Fw AGAGGAGCCCATCCAGCTA
A 
74 95% 0.99 NM_001244
363.1 
 
Rev AGCATTATTACTCATGGTT
GCTGTG 
    
IFN α 
(4) 
Fw CCAACCTCAGCCTTCCTCA
C 
130 198% 0.97 AB369103.1  
Rev TCCTCATTTGTGCCAGGAG
C 
    
IFN β Fw TGCATCCTCCAAATCGCTC
T 
180 128% 0.98 NM_001003
923.1  
 
Rev ATTGAGGAGTCCCAGGCAA
C 
OASL Fw CTAGGCTGCCCCCTCTCTA
T 
100 138% 0.97 NM_001031
790.1 
 
Rev ACGAGGCCTCTGTCCAAAT
G 
    
MX1 Fw GAGGTGGACCCCGAAGGA 57 115% 0.99 M65087 (Diaz-San 
Segundo et 
al., 2010) 
Rev CACCAGATCCGGCTTCGT     
